Enrollment Temporarily Closed
This study is temporarily closed to new enrollments. Please contact the study team for more information or check back frequently.
COMPASS study for metastatic castration-resistant prostate cancer - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
COMPASS: Correlative COMPAnion Study to Predict SYNERGY-201 Clinical Trial Responders
Principal Investigator
Andrew J. Armstrong, MD, MSc
Medical Oncologist
Protocol Number
IRB:
PRO00115687
NCT:
NCT07050433
Phase
Phase N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Enrollment Temporarily Closed